Cannabidiol (CBD) pharmacology
Pro Research Analysisby 
Searched over 200M research papers
Cannabidiol (CBD) Pharmacology: Molecular Targets and Mechanisms
Cannabidiol (CBD) is a major non-psychoactive compound found in Cannabis sativa. Unlike THC, CBD does not cause intoxication or the typical effects associated with cannabis abuse, making it an attractive candidate for therapeutic use in a variety of conditions Castillo-Arellano2023Naya2024Luz-Veiga2023+3 MORE.
CBD’s Molecular Targets and Polypharmacology
CBD interacts with a wide range of molecular targets—over 50 have been identified—including enzymes, ion channels, and metabotropic receptors. These targets are involved in neurological, inflammatory, and immune-related conditions Castillo-Arellano2023Peng2022Vitale2021. While CBD has low affinity for the classical cannabinoid receptors CB1 and CB2, it modulates their activity indirectly and also acts on other receptors such as GPR55, TRPV channels, and PPARγ Peng2022Etemad2022. This broad interaction profile underlies its complex pharmacological effects and therapeutic potential Castillo-Arellano2023Peng2022Vitale2021.
Pharmacokinetics and Safety Profile
CBD’s pharmacokinetics are influenced by factors such as bioavailability, distribution, and the formulation used. The only FDA-approved CBD product, Epidiolex®, has undergone rigorous testing and is considered safe for human use, particularly for childhood-onset seizures. However, the quality and bioavailability of over-the-counter CBD products can vary widely, raising concerns about consistency and efficacy Naya2024Britch2020Naya2023. Overall, clinical and preclinical studies suggest that CBD has a favorable safety profile with limited side effects Britch2020Naya2023.
Mechanisms of Action: Beyond Cannabinoid Receptors
CBD’s effects are not limited to cannabinoid receptors. It acts as an agonist at TRPV1-4 and TRPA1 channels and as an antagonist at TRPM8, which are involved in pain, inflammation, seizures, and vasorelaxation . CBD also modulates serotonin (5-HT1A) receptors, which may contribute to its anxiolytic and antipsychotic effects Peng2022Mandolini2018. Additionally, it influences the endocannabinoid system, glutamatergic, and serotonergic signaling, further expanding its therapeutic reach Peng2022Vitale2021Mandolini2018.
Therapeutic Effects: Anti-Inflammatory, Antioxidant, and Neuroprotective Actions
CBD exhibits significant anti-inflammatory and antioxidant properties, making it a promising candidate for treating diseases associated with oxidative stress and inflammation Naya2024Luz-Veiga2023Atalay2019+2 MORE. It has demonstrated neuroprotective, anticonvulsant, anxiolytic, antipsychotic, analgesic, and anticancer effects in preclinical and some clinical studies Luz-Veiga2023Atalay2019Peng2022+2 MORE. These effects are mediated through its action on multiple molecular pathways, including the modulation of NF-κB and interferon-beta, which are key regulators of immune and inflammatory responses Naya2024Atalay2019.
Clinical Applications and Limitations
CBD is being explored for a wide range of conditions, including epilepsy, pain, neuropsychiatric disorders (such as anxiety and schizophrenia), Alzheimer’s disease, autoimmune diseases, and even as a potential adjunct in COVID-19 management Castillo-Arellano2023Britch2020Luz-Veiga2023+3 MORE. While there is strong evidence for its use in certain types of epilepsy, more rigorous clinical trials are needed to confirm its efficacy for other indications Britch2020Mandolini2018. The variability in product quality and lack of standardization in many commercially available CBD products remain significant challenges .
Conclusion
CBD’s pharmacology is complex and involves interactions with numerous molecular targets beyond the classical cannabinoid receptors. Its broad spectrum of action underlies its therapeutic potential in neurological, inflammatory, and psychiatric disorders. While CBD is generally safe and well-tolerated, further research and standardized clinical trials are needed to fully understand its mechanisms and optimize its use in medical therapies Castillo-Arellano2023Naya2024Britch2020+7 MORE.
Sources and full results
Most relevant research papers on this topic